Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)

NCT01196520

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
Locations
  • Bugando Medical Center Mwanza, Tanzania
  • Shirati Health, Educational, and Development Foundation Shirati, Tanzania
  • St.Mary's Hospital Lacor Gulu, Uganda
  • Kuluva Hospital (Arua) Kampala, Uganda
View Trial Details
Completed

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

NCT00014209

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +12 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Moncton Hospital Moncton, New Brunswick, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
View all 13 locations
View Trial Details
Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • McGill University Montreal, Quebec, Canada
View Trial Details
Completed

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

NCT00031668

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +30 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

NCT00064116

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • The Moncton Hospital Moncton, New Brunswick, Canada
View all 25 locations
View Trial Details
Completed

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

NCT01307267

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center-Investigational Drug Services La Jolla, California, United States
  • UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 42 locations
View Trial Details
Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions